Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Baricitinib is effective and safe for treating severe alopecia areata.

CBD may help restore hair growth-related protein levels in alopecia caused by hormones or other factors.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Midazolam's antiseizure effects are mainly due to synaptic GABA-A receptors, not neurosteroids or extrasynaptic receptors.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

New compounds show promise as nonsteroidal treatments for hair loss.

M50054 may help treat hepatitis and hair loss from chemotherapy.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Mice with CBS deficiency are healthier on a low-methionine diet.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.